Berends et al. (18) performed a mutation analysis of the MLH1, MSH2, and MSH6 genes using Sanger sequencing and MLPA techniques in 57 patients with endometrial cancer, who were younger than 50 years of age. This evidence concerns the gene MLH1 and endometrial cancer.